These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

386 related items for PubMed ID: 16035688

  • 1. Diabetic nephropathy: common questions.
    Thorp ML.
    Am Fam Physician; 2005 Jul 01; 72(1):96-9. PubMed ID: 16035688
    [Abstract] [Full Text] [Related]

  • 2. Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers for prevention and treatment of nephropathy associated with type 2 diabetes mellitus.
    Hughes DB, Britton ML.
    Pharmacotherapy; 2005 Nov 01; 25(11):1602-20. PubMed ID: 16232022
    [Abstract] [Full Text] [Related]

  • 3. Use of losartan in reducing microalbuminuria in normotensive patients with type-2 diabetes mellitus.
    Agha A, Bashir K, Anwar E.
    Nepal Med Coll J; 2007 Jun 01; 9(2):79-83. PubMed ID: 17899953
    [Abstract] [Full Text] [Related]

  • 4. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR.
    Clin Ther; 2007 Sep 01; 29(9):1803-24. PubMed ID: 18035185
    [Abstract] [Full Text] [Related]

  • 5. Improving microvascular outcomes in patients with diabetes through management of hypertension.
    McGill JB.
    Postgrad Med; 2009 Mar 01; 121(2):89-101. PubMed ID: 19332966
    [Abstract] [Full Text] [Related]

  • 6. Rationale and design of a study comparing two fixed-dose combination regimens to reduce albuminuria in patients with type II diabetes and hypertension.
    Bakris GL, Toto RD, McCullough PA.
    J Hum Hypertens; 2005 Feb 01; 19(2):139-44. PubMed ID: 15457206
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Current issues in the diagnosis and therapy of diabetic nephropathy].
    de Châtel R, Mogyorósi A, Ziyadeh FN.
    Orv Hetil; 1997 Jan 26; 138(4):187-93. PubMed ID: 9072751
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Approach to the treatment of diabetic nephropathy.
    Burke JM.
    Pharm Pract Manag Q; 1997 Jul 26; 17(2):26-35. PubMed ID: 10168175
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Risk factors for development and progression of diabetic kidney disease and treatment patterns among diabetic siblings of patients with diabetic kidney disease.
    Bleyer AJ, Sedor JR, Freedman BI, O'Brien A, Russell GB, Graley J, Schelling JR.
    Am J Kidney Dis; 2008 Jan 26; 51(1):29-37. PubMed ID: 18155530
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.